Skip to main content

Table 12 Pooled means of the distribution of the length of stay and crude excess length of stay of intensive care unit patients with and without device-associated healthcare-acquired infection

From: International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

Adult and paediatric ICUs combined

LOS, total days

No. of patients

Pooled average. LOS, days (95% CI)

RR (95% CI)

LOS of patients without DA-HAI

50 716

6,408

7.9 (7.8-7.9)

 

LOS of patients with CLABSI

6,920

357

19.4 (17.5-21.6)

2.4 (2.4 – 2.5)

Extra LOS of patients with CLABSI

6,920

357

11.5 (9.7-13.7)

 

LOS of patients with CAUTI

2,769

154

18.0 (15.4-21.2)

2.3 (2.2 – 2.3)

Extra LOS of patients with CAUTI

2,769

154

10.1 (7.6-13.3)

 

LOS of patients with VAP

9,426

567

16.6 (15.3-18.1)

2.1 (2.0 – 2.1)

Extra LOS of patients with VAP

9,426

567

8.7 (7.5-10.2)

 

Neonatal ICUs combined

LOS, total days

No. of patients

Pooled average LOS, days

 

LOS of patients without DA-HAI

17,547

1,964

8.9 (8.5-9.3)

 

LOS of patients with CLABSI

1,169

53

22.1 (16.9-29.5)

2.6 (2.3 – 2.6)

Extra LOS of patients with CLABSI

1,169

53

13.1 (16.9-9.5)

 

LOS of patients with VAP

1,081

43

25.1 (18.7-35.7)

2.8 (2.6 – 3.0)

Extra LOS of patients with VAP

1,081

43

16.2 (18.7-35.7)

 
  1. LOS, length of stay; DA-HAI, device-associated healthcare-acquired infection; CLABSI, central line-associated bloodstream infection; VAP, ventilator-associated pneumonia; CAUTI, catheter-associated urinary tract infection.